Quantcast
Home > Quotes > CATB

Catabasis Pharmaceuticals, Inc. Common Stock (CATB) Quote & Summary Data

CATB 
$0.5919
*  
0.0326
5.22%
Get CATB Alerts
*Delayed - data as of Dec. 14, 2018  -  Find a broker to begin trading CATB now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 0.6245 / $ 0.5704
Share Volume
323,543
50 Day Avg. Daily Volume
541,711
Previous Close
$ 0.6245
52 Week High / Low
$ 2.38 / $ 0.53
Market Cap
42,047,640
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
323,543
50 Day Avg. Daily Volume:
541,711

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.81

Trading Range

The current last sale of $0.5919 is 11.68% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.6245 $ 2.38
 Low: $ 0.5704 $ 0.53

Company Description (as filed with the SEC)

We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on our proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. Our SMART Linker drug discovery platform enables us to engineer product candidates that can simultaneously modulate multiple targets in a disease. Our proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. We have applied our SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, our primary focus, and plan to pursue partnerships to develop additional product candidates.  ... More ...  


Risk Grade

Where does CATB fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.62
Open Date:
Dec. 14, 2018
Close Price:
$ 0.5929
Close Date:
Dec. 14, 2018

Consensus Recommendation

Analyst Info